Cargando…

p53 and rapamycin are additive

Mechanistic target of rapamycin (mTOR) is a kinase found in a complex (mTORC1) that enables macromolecular synthesis and cell growth and is implicated in cancer etiology. The rapamycin-FK506 binding protein 12 (FKBP12) complex allosterically inhibits mTORC1. In response to stress, p53 inhibits mTORC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christy, Barbara, Demaria, Marco, Campisi, Judith, Huang, Jing, Jones, Diane, Dodds, Sherry G., Williams, Charnae, Hubbard, Gene, Livi, Carolina B., Gao, Xiaoli, Weintraub, Susan, Curiel, Tyler, Sharp, Z. Dave, Hasty, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599238/ https://www.ncbi.nlm.nih.gov/pubmed/26158292

Ejemplares similares

Rapamycin extends life span of Rb1(+/−) mice by inhibiting neuroendocrine tumors
por: Livi, Carolina B., et al.
Publicado: (2013)

Adaptations to chronic rapamycin in mice
por: Dodds, Sherry G., et al.
Publicado: (2016)

A novel suicide gene therapy for the treatment of p16(Ink4a)-overexpressing tumors
por: Kohli, Jaskaren, et al.
Publicado: (2017)

Rapamycin enhances survival in a Drosophila model of mitochondrial disease
por: Wang, Adrienne, et al.
Publicado: (2016)

Rapamycin maintains NAD(+)/NADH redox homeostasis in muscle cells
por: Zhang, Zhigang, et al.
Publicado: (2020)

Heregulin, a new regulator of telomere length in human cells
por: Menendez, Javier A., et al.
Publicado: (2015)

Rapamycin-induced miR-21 promotes mitochondrial homeostasis and adaptation in mTORC1 activated cells
por: Lam, Hilaire C., et al.
Publicado: (2017)

An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma
por: Bever, Katherine M., et al.
Publicado: (2020)

Human thermal perception and time of day: A review
por: Vellei, Marika, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)

AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis
por: Mi, Wenting, et al.
Publicado: (2015)

Heregulin, a new interactor of the telosome/shelterin complex in human telomeres
por: Menendez, Javier A., et al.
Publicado: (2015)

Proteomic quantification of native and ECM-enriched mouse ovaries reveals an age-dependent fibro-inflammatory signature
por: Dipali, Shweta S., et al.
Publicado: (2023)

Divergent tissue and sex effects of rapamycin on the proteasome-chaperone network of old mice
por: Rodriguez, Karl A., et al.
Publicado: (2014)

Gene expression signatures of human senescent corneal and conjunctival epithelial cells
por: Kitazawa, Koji, et al.
Publicado: (2023)

Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice
por: Hurez, Vincent, et al.
Publicado: (2015)

p53-independent p21 induction by MELK inhibition
por: Matsuda, Tatsuo, et al.
Publicado: (2017)

Cdkn1a transcript variant 2 is a marker of aging and cellular senescence
por: López-Domínguez, José Alberto, et al.
Publicado: (2021)

Acarbose improved survival for Apc(+/Min) mice
por: Dodds, Sherry G., et al.
Publicado: (2020)

p53-regulated autophagy is controlled by glycolysis and determines cell fate
por: Duan, Lei, et al.
Publicado: (2015)

p21 can be a barrier to ferroptosis independent of p53
por: Venkatesh, Divya, et al.
Publicado: (2020)

Identification of a p53-repressed gene module in breast cancer cells
por: Miyamoto, Takafumi, et al.
Publicado: (2017)

cep-1/p53-dependent dysplastic pathology of the aging C. elegans gonad
por: McGee, Mathew D., et al.
Publicado: (2012)

p53 as an intervention target for cancer and aging
por: Hasty, Paul, et al.
Publicado: (2013)

Selected drugs that inhibit DNA methylation can preferentially kill p53 deficient cells
por: Yi, Lan, et al.
Publicado: (2014)

TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity
por: Chen, Dongshi, et al.
Publicado: (2014)

NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
por: Wu, Nan, et al.
Publicado: (2016)

p53 elevation in human cells halt SV40 infection by inhibiting T-ag expression
por: Drayman, Nir, et al.
Publicado: (2016)

Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity
por: Sriraman, Anusha, et al.
Publicado: (2016)

Loss of p53-inducible long non-coding RNA LINC01021 increases chemosensitivity
por: Kaller, Markus, et al.
Publicado: (2017)

Tumor Trp53 status and genotype affect the bone marrow microenvironment in acute myeloid leukemia
por: Jacamo, Rodrigo, et al.
Publicado: (2017)

Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
por: Tal, Perry, et al.
Publicado: (2016)

Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB
por: Hu, Ying, et al.
Publicado: (2015)

Addiction to Runx1 is partially attenuated by loss of p53 in the Eμ-Myc lymphoma model
por: Borland, Gillian, et al.
Publicado: (2016)

Remote intracranial recurrence of IDH mutant gliomas is associated with TP53 mutations and an 8q gain
por: Nakae, Shunsuke, et al.
Publicado: (2017)

Genome-wide analysis of p53 transcriptional programs in B cells upon exposure to genotoxic stress in vivo
por: Tonelli, Claudia, et al.
Publicado: (2015)

Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging
por: Li, Tongyuan, et al.
Publicado: (2016)

A negative feedback regulatory loop between miR-138 and TP53 is mediated by USP10
por: Luo, Zhenghua, et al.
Publicado: (2019)

Loss of p53 enhances the function of the endoplasmic reticulum through activation of the IRE1α/XBP1 pathway
por: Namba, Takushi, et al.
Publicado: (2015)

Mdm2 inhibition confers protection of p53-proficient cells from the cytotoxic effects of Wee1 inhibitors
por: Li, Yizhu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f60dfp7qpd5hsktlcts3af4k6j